Proteomic analysis of breast cancer tissue reveals upregulation of actin-remodeling proteins and its relevance to cancer invasiveness

Proteomics - Clinical Applications

Volumn 3, Issue 1, 2009, Pages 30-40

  Kim, Dong Hyun ^a   Bae, Jinhee ^a   Lee, Jong Won ^b   Kim, Seon Young ^c   Kim, Yong Hak ^a   Bae, Ji Yeon ^b   Yi, Jae Kyo ^b   Yu, Myeong Hee ^a   Noh, Dong Young ^b   Lee, Cheolju ^a  

^a Korea Institute of Science and Technology   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

Arp2 3 complex subunit 2; Breast cancer; Coronin 1A; DIGE; Invasion assay

Indexed keywords

ACTIN; ACTIN INTERACTIN PROTEIN 1; ACTIN RELATED PROTEIN 2; ADENOSINE KINASE; ADENOSYLHOMOCYSTEINASE; CARBONATE DEHYDRATASE I; CELL PROTEIN; CORONIN 1A; CYTOSOL AMINOPEPTIDASE; ELONGATION FACTOR 1; ELONGATION FACTOR 2; ENOLASE; FATTY ACID BINDING PROTEIN; FIBRINOGEN; GELSOLIN; GLUTAMATE AMMONIA LIGASE; GLYCINE TRANSFER RNA LIGASE; HEAT SHOCK PROTEIN; IMMUNOGLOBULIN; LIPOCORTIN 1; MESSENGER RNA; MOESIN; PROTEIN P34 ARC; REGULATOR PROTEIN; RETINAL DEHYDROGENASE; RIBOSOME PROTEIN; SERUM ALBUMIN; SMALL INTERFERING RNA; TRYPTOPHAN TRANSFER RNA LIGASE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER INVASION; CLINICAL ARTICLE; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN QUATERNARY STRUCTURE; UPREGULATION;

EID: 65549126447     PISSN: 18628346     EISSN: None     Source Type: Journal    
DOI: 10.1002/prca.200800167     Document Type: Article

References (39)

1. Veronesi, U., Boyle, P., Goldhirsch, A., Orecchia, R., Viale, G., Breast cancer. Lancet 2005, 365, 1727-1741.
2. White, S. L., Gharbi, S., Bertani, M. F., Chan, H. L. et al., Cellular responses to ErbB-2 overexpression in human mammary luminal epithelial cells: Comparison of mRNA and protein expression. Br. J. Cancer 2004, 90, 173-181.
3. Bertucci, F., Birnbaum, D., Goncalves, A., Proteomics of breast cancer: Principles and potential clinical applications. Mol. Cell. Proteomics 2006, 5, 1772-1786.
4. Smith, L., Lind, M. J., Welham, K. J., Cawkwell, L., Cancer proteomics and its application to discovery of therapy response markers in human cancer. Cancer 2006, 107, 232-241.
5. Alban, A., David, S. O., Bjorkesten, L., Andersson, C. et al., A novel experimental design for comparative two-dimensional gel analysis: Two-dimensional difference gel electrophoresis incorporating a pooled internal standard. Proteomics 2003, 3, 36-44.
6. Tonge, R., Shaw, J., Middleton, B., Rowlinson, R. et al., Validation and development of fluorescence two-dimensional differential gel electrophoresis proteomics technology. Proteomics 2001, 1, 377-396.
7. Boudreau, N., Myers, C., Breast cancer-induced angiogenesis: Multiple mechanisms and the role of the micro-environment. Breast Cancer Res. 2003, 5, 140-146.
8. 18O isotopic labeling. J. Proteome Res. 2004, 3, 604-612.
9. Zhang, D., Tai, L. K., Wong, L. L., Chiu, L. L. et al., Proteomic study reveals that proteins involved in metabolic and detoxification pathways are highly expressed in HER-2/neu-positive breast cancer. Mol. Cell. Proteomics 2005, 4, 1686-1696.
10. Lee, J. E., Kim, H. J., Bae, J. Y., Kim, S. W. et al., Neogenin expression may be inversely correlated to the tumorigenicity of human breast cancer. BMC Cancer 2005, 5, 154.
11. Chang, J. W., Kang, U.-B., Kim, D. H., Yi, J. K. et al., Identification of circulating endorepellin LG3 fragment: Potential use as a serological biomarker for breast cancer. Proteomics Clin. Appl. 2008, 2, 23-32.
12. Friedman, D. B., Quantitative proteomics for two-dimensional gels using difference gel electrophoresis. Methods Mol. Biol. 2007, 367, 219-239.
13. Ryu, M. J., Kim, D., Kang, U. B., Kim, J. et al., Proteomic analysis of γ-butyrolactone-treated mouse thalamus reveals dysregulated proteins upon absence seizure. J. Neurochem. 2007, 102, 646-656.
14. Tas, F., Hansel, H., Belce, A., Ilvan, S. et al., Oxidative stress in breast cancer. Med. Oncol. 2005, 22, 11-15.
15. Balinsky, D., Platz, C. E., Lewis, J. W., Isozyme patterns of normal, benign, and malignant human breast tissues. Cancer Res. 1983, 43, 5895-5901.
16. Florianczyk, B., Pasternak, K., Grzybowska, L., Peszynski, J., Activity of isocitrate dehydrogenase in breast cancer. Pol. Merkur. Lekarski 1997, 2, 376-377.
17. Wang, Y., He, Q. Y., Chen, H., Chiu, J. F., Synergistic effects of retinoic acid and tamoxifen on human breast cancer cells: Proteomic characterization. Exp. Cell Res. 2007, 313, 357-368.
18. Reinerova, M., Veselovska, Z., Ausch, C., Rosen, H. R., Immunosuppressive activity of lymphocyte mitogenesis by breast cancer-associated p43. Neoplasma 1996, 43, 363-366.
19. Laguens, G. E., Coronato, S., Spinelli, O., Laguens, R. P., Di Girolamo, W., Can breast cancer Hsp 27 (Heat Shock Protein 27000) expression influence axillary lymph node status? Breast 2001, 10, 179-181.
20. Carmeci, C., Thompson, D. A., Kuang, W. W., Lightdale, N. et al., Moesin expression is associated with the estrogen receptor-negative breast cancer phenotype. Surgery 1998, 124, 211-217.
21. Le Naour, F., Misek, D. E., Krause, M. C., Deneux, L. et al., Proteomics-based identification of RS/DJ-1 as a novel circulating tumor antigen in breast cancer. Clin. Cancer Res. 2001, 7, 3328-3335.
22. Ono, S., Regulation of actin filament dynamics by actin depolymerizing factor/cofilin and actin-interacting protein 1: New blades for twisted filaments. Biochemistry 2003, 42, 13363-13370.
23. Goldberg, D. J., Foley, M. S., Tang, D., Grabham, P. W., Recruitment of the Arp2/3 complex and mena for the stimulation of actin polymerization in growth cones by nerve growth factor. J. Neurosci. Res. 2000, 60, 458-467.
24. Goley, E. D., Welch, M. D., The ARP2/3 complex: An actin nucleator comes of age. Nat. Rev. Mol. Cell Biol. 2006, 7, 713-726.
25. Lambrechts, A., Van Troys, M., Ampe, C., The actin cytoskeleton in normal and pathological cell motility. Int. J. Biochem. Cell Biol. 2004, 36, 1890-1909.
26. Uetrecht, A. C., Bear, J. E., Coronins: The return of the crown. Trends Cell Biol. 2006, 16, 421-426.
27. Rybakin, V., Clemen, C. S., Coronin proteins as multi-functional regulators of the cytoskeleton and membrane trafficking. Bioessays 2005, 27, 625-632.
28. Cai, L., Marshall, T. W., Uetrecht, A. C., Schafer, D. A., Bear, J. E., Coronin 1B coordinates Arp2/3 complex and cofilin activities at the leading edge. Cell 2007, 128, 915-929.
29. Honda, K., Yamada, T., Endo, R., Ino, Y. et al., Actinin-4, a novel actin-bundling protein associated with cell motility and cancer invasion. J. Cell Biol. 1998, 140, 1383-1393.
30. Yamaguchi, H., Condeelis, J., Regulation of the actin cytoskeleton in cancer cell migration and invasion. Biochim. Biophys. Acta 2007, 1773, 642-652.
31. Chhabra, E. S., Higgs, H. N., The many faces of actin: Matching assembly factors with cellular structures. Nat. Cell Biol. 2007, 9, 1110-1121.
32. Pawitan, Y., Bjohle, J., Amler, L., Borg, A. L. et al., Gene expression profiling spares early breast cancer patients from adjuvant therapy: Derived and validated in two population-based cohorts. Breast Cancer Res. 2005, 7, R953-R964.
33. Wang, Y., Klijn, J. G., Zhang, Y., Sieuwerts, A. M. et al., Gene-expression profiles to predict distant metastasis of lymphnode-negative primary breast cancer. Lancet 2005, 365, 671-679.
34. Sorlie, T., Perou, C. M., Tibshirani, R., Aas, T. et al., Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl. Acad. Sci. USA 2001, 98, 10869-10874.
35. Miller, L. D., Smeds, J., George, J., Vega, V. B. et al., An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. Proc. Natl. Acad. Sci. USA 2005, 102, 13550-13555.
36. Vaquerizas, J. M., Conde, L., Yankilevich, P., Cabezon, A. et al., GEPAS, an experiment-oriented pipeline for the analysis of microarray gene expression data. Nucleic Acids Res. 2005, 33, W616-W620.
37. Machesky, L. M., Reeves, E., Wientjes, F., Mattheyse, F. J. et al., Mammalian actin-related protein 2/3 complex localizes to regions of lamellipodial protrusion and is composed of evolutionarily conserved proteins. Biochem. J. 1997, 328, 105-112.
38. Bryce, N. S., Clark, E. S., Leysath, J. L., Currie, J. D. et al., Cortactin promotes cell motility by enhancing lamellipodial persistence. Curr. Biol. 2005, 15, 1276-1285.
39. Pollard, T. D., Borisy, G. G., Cellular motility driven by assembly and disassembly of actin filaments. Cell 2003, 112, 453-465.